Description

The Retatrutide 10 mg Pen is a research-grade, pre-filled injection pen designed for once-weekly dosing of the investigational triple agonist peptide. Retatrutide activates GLP-1, GIP, and glucagon receptors, offering a unique mechanism for weight loss, appetite suppression, and improved metabolic health.

Although not yet approved for medical use in the UK or worldwide (currently in Phase 3 trials), the 10 mg pen is one of the most widely distributed research versions. It provides a convenient delivery method for consistent dosing, making it a popular format among research suppliers.